Delivery Order SPE2DX22D0010-SPE2D825FBZ76

Award Date 12/18/24
Potential Completion Date 12/19/24
Potential Value $3.5K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D825FBZ76
    Delivery Order

This federal contract award, with ID SPE2DX22D0010|SPE2D825FBZ76, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,491.56 Firm Fixed Price delivery order is for the supply of 4566753361 - Oxymorphone HCL ER Tablets 7.5mg. The contract has an ultimate completion date of December 19, 2024 and was awarded on December 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC encompasses a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 3/19/25, 9:52 AM